• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Concept Life Sciences expands into Alderley Park in U.K.

Concept Life Sciences expands into Alderley Park in U.K.

September 22, 2017
CenterWatch Staff

Concept Life Sciences, an integrated drug discovery, development and analytical services company, has expanded into new state-of-the-art laboratory space at Alderley Park in Cheshire, U.K. The move supports the growth of the Company’s integrated discovery services business, adding capacity and bringing key disciplines together into one location.

The new laboratory space will increase Concept’s scientific capacity by over 30%, adding 75 FTEs to the company, including 55 scientists (medicinal chemists and biologists) over the two facilities, which total 12,400 square feet.

Concept’s drug discovery services encompass medicinal chemistry, pharmacology screening, assay development, and ADME, supporting biotech and pharma companies by adding value and IP to their small molecule discovery programs. Adding capacity and co-locating these capabilities will further enable the Company to provide a truly integrated offering, spanning the discovery and development continuum.

“This significant investment will enable us to put in place the expertise to support Concept Life Sciences’ projected growth into 2018 and beyond,” said Michael Fort, Executive Chairman, Concept Life Sciences. “The expansion to the Mereside campus at Alderley Park is a pivotal step in the development of the group’s corporate and commercial profile to its international client base, opening new opportunities for collaboration and growth, markedly increasing the depth of our scientific offering and capitalizing on Concept’s strong track record of delivery.”

“We welcome Concept to the Mereside campus, where the Company will benefit from the world class science facilities and access to talent. We are proud of the scientific ecosystem that exists here at Alderley Park and within the wider network of Manchester Science Partnerships, where we have close links with Universities, NHS institutions and research organisations,” commented Dr Chris Doherty, Managing Director at Alderley Park. “Concept Life Sciences’ track record shows a great deal of progress in a short space of time, and the new Alderley Park base will provide the laboratory and office infrastructure required to help maintain their recent momentum.”

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing